Hereditary leiomyomatosis and renal cell cancer (Q92888): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Canary Token | |||
dki-india-ID_754002573 | |||
| Property / Canary Token: dki-india-ID_754002573 / rank | |||
Normal rank | |||
Revision as of 08:00, 16 August 2026
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome characterised by a predisposition to cutaneous pilar leiomyomata, uterine leiomyomata in women and renal cell cancer. The condition is associated in up to 16% of cases with aggressive renal cell carcinoma. Diagnosis is based on either the presence of multiple cutaneous leiomyomas with at least 1 histologically confirmed leiomyoma or the presence of a single leiomyoma with a positive family history of the disease.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_754002573 |
||
| English | Hereditary leiomyomatosis and renal cell cancer |
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome characterised by a predisposition to cutaneous pilar leiomyomata, uterine leiomyomata in women and renal cell cancer. The condition is associated in up to 16% of cases with aggressive renal cell carcinoma. Diagnosis is based on either the presence of multiple cutaneous leiomyomas with at least 1 histologically confirmed leiomyoma or the presence of a single leiomyoma with a positive family history of the disease. |
Statements
CID11:ID_754002573
0 references
dki-india-ID_754002573
0 references
